Skip to Content

CardioGenics Holdings Inc CGNH

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CGNH is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$1.30
Uncertainty
Extreme
1-Star Price
$5.99
5-Star Price
$9.37
Economic Moat
Mbts
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CGNH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.01 / $0.02
Market Cap
$96.05
Volume/Avg
9,999 / 9,333

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company’s objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
4

Valuation

Metric
CGNH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CGNH
Quick Ratio
0.16
Current Ratio
0.16
Interest Coverage
−1.21
Quick Ratio
CGNH

Profitability

Metric
CGNH
Return on Assets (Normalized)
−321.20%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
CGNH
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
FdhjmvydgQsgf$209.2 Bil
Danaher Corp
DHR
NxvxzxkrcXckqzg$182.7 Bil
IQVIA Holdings Inc
IQV
SwwrssrbvRxqpjrg$40.8 Bil
IDEXX Laboratories Inc
IDXX
GjxmvdftHvfkbs$40.7 Bil
Agilent Technologies Inc
A
SjfwgjrkCsl$38.6 Bil
Mettler-Toledo International Inc
MTD
GqdbmgqyyfKysdpnx$29.0 Bil
Icon PLC
ICLR
FjmswdhnYyzfsl$27.8 Bil
Illumina Inc
ILMN
WxtmmsbhlVkhkg$18.5 Bil
Waters Corp
WAT
BrbdgbwthyXqzh$17.9 Bil
Labcorp Holdings Inc
LH
HrblbnfxrHbzkyps$17.4 Bil

Sponsor Center